Pluristem Therapeutics
Why Robinhood?
You can watch PSTI and buy or sell other stocks, ETFs, and their options commission-free!About PSTI
Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions.
PSTI Key Statistics
Stock Snapshot
As of today, Pluristem Therapeutics(PSTI) shares are valued at $3.85. The company's market cap stands at 31.43M, with a P/E ratio of -1.18.
Pluristem Therapeutics(PSTI) stock opened on 2026-02-06 at —. The price climbed to — and dipped to —.
The Pluristem Therapeutics(PSTI)'s current trading volume is 0, compared to an average daily volume of 15.41K.
In the last year, Pluristem Therapeutics(PSTI) shares hit a 52-week high of $7.13 and a 52-week low of $2.82.
In the last year, Pluristem Therapeutics(PSTI) shares hit a 52-week high of $7.13 and a 52-week low of $2.82.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.